These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 3168695

  • 61. An enteric-coated high-buffered pancrelipase reduces steatorrhea in patients with cystic fibrosis: a prospective, randomized study.
    Brady MS, Garson JL, Krug SK, Kaul A, Rickard KA, Caffrey HH, Fineberg N, Balistreri WF, Stevens JC.
    J Am Diet Assoc; 2006 Aug; 106(8):1181-6. PubMed ID: 16863712
    [Abstract] [Full Text] [Related]

  • 62. [In vitro study of a new pancreatic enzyme with high lipase content in enteric coated microtablets].
    Vantini I, Fioretta A, Bonfante F, Brentegnani MT, Benini L, Castellani G.
    Clin Ter; 1993 May; 142(5):445-51. PubMed ID: 8339528
    [Abstract] [Full Text] [Related]

  • 63. Pancrelipase delayed-release capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: A double-blind randomized trial.
    Whitcomb DC, Lehman GA, Vasileva G, Malecka-Panas E, Gubergrits N, Shen Y, Sander-Struckmeier S, Caras S.
    Am J Gastroenterol; 2010 Oct; 105(10):2276-86. PubMed ID: 20502447
    [Abstract] [Full Text] [Related]

  • 64.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 65. Novel ciliate lipases for enzyme replacement during exocrine pancreatic insufficiency.
    Brock A, Aldag I, Edskes S, Hartmann M, Herzog T, Uhl W, Schnekenburger J.
    Eur J Gastroenterol Hepatol; 2016 Nov; 28(11):1305-12. PubMed ID: 27518039
    [Abstract] [Full Text] [Related]

  • 66. Comparison of two enteric coated microsphere preparations in the treatment of pancreatic exocrine insufficiency caused by cystic fibrosis.
    Santini B, Antonelli M, Battistini A, Bertasi S, Collura M, Esposito I, Di Febbraro L, Ferrari R, Ferrero L, Iapichino L, Lucidi V, Manca A, Pisconti CL, Pisi G, Raia V, Romano L, Rosati P, Grazioli I, Melzi G.
    Dig Liver Dis; 2000 Nov; 32(5):406-11. PubMed ID: 11030186
    [Abstract] [Full Text] [Related]

  • 67. Comparison of gastrointestinal pH in cystic fibrosis and healthy subjects.
    Youngberg CA, Berardi RR, Howatt WF, Hyneck ML, Amidon GL, Meyer JH, Dressman JB.
    Dig Dis Sci; 1987 May; 32(5):472-80. PubMed ID: 3646103
    [Abstract] [Full Text] [Related]

  • 68. Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: a multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study.
    Graff GR, Maguiness K, McNamara J, Morton R, Boyd D, Beckmann K, Bennett D.
    Clin Ther; 2010 Jan; 32(1):89-103. PubMed ID: 20171415
    [Abstract] [Full Text] [Related]

  • 69. [Treatment of exocrine pancreatic insufficiency: what gastroprotection do pancreatic enzymes provide?].
    Zylberberg P, Delchier JC.
    Gastroenterol Clin Biol; 1993 Jan; 17(11):816-22. PubMed ID: 8143947
    [No Abstract] [Full Text] [Related]

  • 70. Preparation and in vivo efficacy study of pancreatin microparticles as an enzyme replacement therapy for pancreatitis.
    Naikwade SR, Meshram RN, Bajaj AN.
    Drug Dev Ind Pharm; 2009 Apr; 35(4):417-32. PubMed ID: 18850362
    [Abstract] [Full Text] [Related]

  • 71. Enzyme replacement therapy of exocrine pancreatic insufficiency in man. Relations between in vitro enzyme activities and in vivo potency in commercial pancreatic extracts.
    Graham DY.
    N Engl J Med; 1977 Jun 09; 296(23):1314-7. PubMed ID: 16212
    [Abstract] [Full Text] [Related]

  • 72.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 73. Enzyme treatment of exocrine pancreatic insufficiency in chronic pancreatitis.
    Lankisch PG.
    Digestion; 1993 Jun 09; 54 Suppl 2():21-9. PubMed ID: 8224569
    [Abstract] [Full Text] [Related]

  • 74. [Treatment of exocrine pancreatic insufficiency: where can progress come from?].
    Gosselin M.
    Gastroenterol Clin Biol; 1988 Nov 09; 12(11):783-6. PubMed ID: 3220230
    [No Abstract] [Full Text] [Related]

  • 75. Efficacy of pancrease: crossover comparative study versus eurobiol in cystic fibrosis.
    Chazalette JP, Dain MP, Castaigne JP.
    J Pediatr Gastroenterol Nutr; 1988 Nov 09; 7 Suppl 1():S46-8. PubMed ID: 3042939
    [Abstract] [Full Text] [Related]

  • 76. Randomised clinical trial: a 1-week, double-blind, placebo-controlled study of pancreatin 25 000 Ph. Eur. minimicrospheres (Creon 25000 MMS) for pancreatic exocrine insufficiency after pancreatic surgery, with a 1-year open-label extension.
    Seiler CM, Izbicki J, Varga-Szabó L, Czakó L, Fiók J, Sperti C, Lerch MM, Pezzilli R, Vasileva G, Pap A, Varga M, Friess H.
    Aliment Pharmacol Ther; 2013 Apr 09; 37(7):691-702. PubMed ID: 23383603
    [Abstract] [Full Text] [Related]

  • 77. A double-blind, randomized, multicentre, crossover study to prove equivalence of pancreatin minimicrospheres versus microspheres in exocrine pancreatic insufficiency.
    Halm U, Löser C, Löhr M, Katschinski M, Mössner J.
    Aliment Pharmacol Ther; 1999 Jul 09; 13(7):951-7. PubMed ID: 10383531
    [Abstract] [Full Text] [Related]

  • 78. Pancreatic enzyme therapy for pancreatic exocrine insufficiency.
    Domínguez-Muñoz JE.
    Curr Gastroenterol Rep; 2007 Apr 09; 9(2):116-22. PubMed ID: 17418056
    [Abstract] [Full Text] [Related]

  • 79. Efficacy and Safety of Pancrelipase/Pancreatin in Patients With Exocrine Pancreatic Insufficiency and a Medical History of Diabetes Mellitus.
    Whitcomb DC, Bodhani A, Beckmann K, Sander-Struckmeier S, Liu S, Fuldeore M, Pollack PF, Khurmi RP.
    Pancreas; 2016 Apr 09; 45(5):679-86. PubMed ID: 26495784
    [Abstract] [Full Text] [Related]

  • 80.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.